Grants Search Results

This grant supports a nurse navigator to ensure that more kids can be treated on clinical trials, often their best hope for a cure.

This grant supports personnel to ensure that more kids can be treated on clinical trials, often their best hope for a cure.

Adolescent and Young Adult (AYA) patients with cancer form a unique group, different than both little children and older adults with cancer. Historically the AYA cancer population has delayed access to care, delay in diagnosis, inconsistent treatment and follow-up, and decreased participation in clinical trials, often leading to inferior survival and quality of life compared to either younger children or older adults. Stony Brook Cancer Center recently started a formal AYA cancer program, with the goal of providing enhanced care and research for AYA patients. This grant supports a nurse navigator for the AYA program, to ensure that more kids can be treated on clinical trials, often their best hope for a cure.

This grant supports a Clinical Research Associate to ensure that more kids can be treated on clinical trials, often their best hope for a cure.

Adolescent and young adults with cancer (AYAs) represent a unique group of patients that do not do as well on treatment when compared to younger children and older adults. There are many reasons why AYAs do not do as well, which include the specific types of cancers that affect this age group, poor participation in clinical trials, psychosocial challenges of being a teenager with a cancer diagnosis, and the location of cancer treatment. This grant supports the development of an AYA program that will help meet the specific needs of this patient population, with a focus on increased access to clinical trials, to improve overall outcomes.

This grant supports a Clinical Research Associate to ensure that more kids can be treated on clinical trials, often their best hope for a cure.

This grant supports a Clinical Research Coordinator to ensure that more kids can be treated on clinical trials, often their best hope for a cure.

This grant supports an Adolescent and Young Adult (AYA) Clinical Research Nurse to ensure that more AYAs can be treated on clinical trials, often their best hope for a cure.

Fortunately, the majority of children with cancer can be cured of their disease. For those children that are not cured, new therapies and new approaches are needed. Additionally, for those children who are cured, we need to work on decreasing the risk of long-term side effects by understanding how chemotherapy medications are metabolized in each individual patient and developing more targeted therapies to decrease off-target side effects. Children's Hospital & Research Center Oakland is currently in process of developing a tumor/tissue bank in order to have patient samples available for collaborative researchers to help tackle some of these questions in order to improve the outcomes and side effects for children with cancer. Some of the research collaborators who are currently utilizing samples from the tumor bank are looking at new methods to harness the immune system to help with killing cancer cells which can minimize some of the side effects from chemotherapy. Additionally they are using samples from the tumor bank to look at the genetics of each person's particular cancer to help identify potential therapeutic targets. Researchers can also utilize this genetic information to answer other genetic questions such as why certain patients metabolism certain chemotherapy medications so differently than other patients and ultimately why certain drugs appear more effective in certain patients than others. This grant supports a Clinical Research Associate to support the tumor/tissue bank.

This grant supports a Clinical Research Associate to ensure that more kids can be treated on clinical trials, often their best hope for a cure.

This grant supports a Clinical Research Associate to ensure that more kids can be treated on clinical trials, often their best hope for a cure.

This grant supports a Clinical Research Associate to ensure that more kids can be treated on clinical trials, often their best hope for a cure.

This grant supports the Childhood Cancer Survivorship Program at Valley Children's Hospital, providing critical patient data for survivorship researchers.

Childhood cancer kills more children each year in the US than any other disease. Upstate Golisano Children's Hospital's mission is to conquer childhood cancer through superior care, research, and comprehensive support. Upstate Golisano Children's Hospital provides the medical expertise for children, adolescents, and young adults in the central New York area. They do this by participating in national treatment trials sponsored by the Children's Oncology Group (COG). This grant supports a Clinical Research Associate to ensure that more kids can be treated on clinical trials, often their best hope for a cure.

The Center for Cancer and Blood Disorders at Phoenix Children's Hospital is the only program in the Southwest offering phase I clinical trials for children with cancer, enabling patients to receive the newest, most promising treatments available. These studies are critical for patients whose cancers cannot be cured by currently available treatments. The Early Drug Development Program Clinical Research Assistant supported by this grant will help to conduct these cutting edge trials.

This grant supports a Clinical Research Nurse to ensure that more kids can be treated on clinical trials, often their best hope for a cure. In the past, children diagnosed with cancer in the Rio Grande Valley had to travel to cities such as Houston or San Antonio to get state-or-the-art treatment through clinical trials. Physicians at the Vannie Cook Clinic in the Rio Grande Valley now have access to the most advanced trials and latest medications through Children’s Oncology Group and other Texas-based clinical trials. This gives patients the opportunity to have the optimal outcome from their cancer therapy. More importantly, parents know that their child is getting the best care available, anywhere. That gives families hope that their child will live a long, healthy life.

Pediatric cancer research remains limited by a lack of data sharing. While clinical trials remain the cornerstone of pediatric cancer breakthroughs, a consistent and reliable way to store and share data from these trials is lacking. The University of Chicago Pediatric Cancer Data Commons was established to solve this important problem. Sitting alongside the NCI's Genomic Data Commons, the PCDC serves as a neutral repository for data from clinical trials. This information is first converted into a commons format that is consistent across pediatric cancers. The PCDC allows researchers to search over thousands of patients' data to see quickly what data are available for study. Researchers can then apply for access to data, and the PCDC streamlines the process of requesting and downloading data. Finally, the PCDC connects researchers to other kinds of data, including genomic information so critical to studying pediatric cancer. This grant supports personnel to help build the PCDC, so that researchers can efficiently access data and create new ways to study pediatric cancer.

This grant supports a Clinical Research Associate to ensure that more kids can be treated on clinical trials, often their best hope for a cure.

This grant supports the Nurse Researchers in the UIC/Rush/Stroger COG Program to ensure more kids can be treated on clinical trials, often their best hope for a cure.

This grant supports personnel to ensure that more kids can be treated on clinical trials, often their best hope for a cure.